Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Brainsway Ltd. Sponsored ADR stock logo
BWAY
Brainsway
$11.61
-4.4%
$11.27
$5.98
$13.66
$219.43M1.468,741 shs245,349 shs
SEPA
SEP Acquisition
$10.32
+1.3%
$10.19
$7.86
$17.00
$59.96M0.1511,589 shs7,000 shs
Neuronetics, Inc. stock logo
STIM
Neuronetics
$3.83
+6.4%
$3.78
$0.52
$5.92
$253.20M1.85845,851 shs1.19 million shs
Tactile Systems Technology, Inc. stock logo
TCMD
Tactile Systems Technology
$10.01
+2.2%
$10.00
$8.61
$21.10
$232.73M0.95250,595 shs262,927 shs
(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Brainsway Ltd. Sponsored ADR stock logo
BWAY
Brainsway
-0.41%-6.54%+9.86%+47.45%+81.89%
SEPA
SEP Acquisition
0.00%0.00%0.00%0.00%0.00%
Neuronetics, Inc. stock logo
STIM
Neuronetics
-3.74%+2.86%-1.37%-4.26%+80.00%
Tactile Systems Technology, Inc. stock logo
TCMD
Tactile Systems Technology
+1.35%-3.36%-1.01%-26.56%-23.22%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Brainsway Ltd. Sponsored ADR stock logo
BWAY
Brainsway
2.6441 of 5 stars
2.54.00.00.02.70.81.9
SEPA
SEP Acquisition
N/AN/AN/AN/AN/AN/AN/AN/A
Neuronetics, Inc. stock logo
STIM
Neuronetics
1.7841 of 5 stars
3.31.00.00.01.91.70.6
Tactile Systems Technology, Inc. stock logo
TCMD
Tactile Systems Technology
3.7191 of 5 stars
3.02.00.00.03.22.53.1
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Brainsway Ltd. Sponsored ADR stock logo
BWAY
Brainsway
3.00
Buy$14.2522.74% Upside
SEPA
SEP Acquisition
0.00
N/AN/AN/A
Neuronetics, Inc. stock logo
STIM
Neuronetics
2.67
Moderate Buy$5.5043.60% Upside
Tactile Systems Technology, Inc. stock logo
TCMD
Tactile Systems Technology
2.00
Hold$16.0059.84% Upside

Current Analyst Ratings Breakdown

Latest SEPA, STIM, BWAY, and TCMD Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
6/9/2025
Brainsway Ltd. Sponsored ADR stock logo
BWAY
Brainsway
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$16.00
5/7/2025
Tactile Systems Technology, Inc. stock logo
TCMD
Tactile Systems Technology
B. Riley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeHold
5/6/2025
Tactile Systems Technology, Inc. stock logo
TCMD
Tactile Systems Technology
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeOverweight ➝ Neutral$25.00 ➝ $14.00
(Data available from 7/17/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Brainsway Ltd. Sponsored ADR stock logo
BWAY
Brainsway
$41.02M5.35$0.24 per share48.92$3.31 per share3.51
SEPA
SEP Acquisition
N/AN/AN/AN/A($0.63) per shareN/A
Neuronetics, Inc. stock logo
STIM
Neuronetics
$74.89M3.38N/AN/A$0.57 per share6.72
Tactile Systems Technology, Inc. stock logo
TCMD
Tactile Systems Technology
$292.98M0.79$1.12 per share8.93$9.03 per share1.11
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Brainsway Ltd. Sponsored ADR stock logo
BWAY
Brainsway
$2.92M$0.2058.0572.56N/A9.01%7.35%4.72%8/5/2025 (Estimated)
SEPA
SEP Acquisition
-$2.36MN/A0.00N/AN/AN/A-38.32%N/A
Neuronetics, Inc. stock logo
STIM
Neuronetics
-$43.71M-$1.31N/AN/AN/A-53.67%-174.15%-38.41%8/11/2025 (Estimated)
Tactile Systems Technology, Inc. stock logo
TCMD
Tactile Systems Technology
$16.96M$0.6615.1711.92N/A5.52%8.41%6.10%8/4/2025 (Estimated)

Latest SEPA, STIM, BWAY, and TCMD Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/11/2025Q2 2025
Neuronetics, Inc. stock logo
STIM
Neuronetics
-$0.08N/AN/AN/A$36.80 millionN/A
8/5/2025Q2 2025
Brainsway Ltd. Sponsored ADR stock logo
BWAY
Brainsway
$0.07N/AN/AN/A$12.34 millionN/A
8/4/2025Q2 2025
Tactile Systems Technology, Inc. stock logo
TCMD
Tactile Systems Technology
$0.09N/AN/AN/A$73.93 millionN/A
5/13/2025Q1 2025
Brainsway Ltd. Sponsored ADR stock logo
BWAY
Brainsway
$0.02$0.04+$0.02$0.04$11.45 million$11.54 million
5/6/2025Q1 2025
Neuronetics, Inc. stock logo
STIM
Neuronetics
-$0.13-$0.21-$0.08-$0.21$29.07 million$31.98 million
5/5/2025Q1 2025
Tactile Systems Technology, Inc. stock logo
TCMD
Tactile Systems Technology
-$0.07-$0.13-$0.06-$0.13$63.48 million$61.27 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Brainsway Ltd. Sponsored ADR stock logo
BWAY
Brainsway
N/AN/AN/AN/AN/A
SEPA
SEP Acquisition
N/AN/AN/AN/AN/A
Neuronetics, Inc. stock logo
STIM
Neuronetics
N/AN/AN/AN/AN/A
Tactile Systems Technology, Inc. stock logo
TCMD
Tactile Systems Technology
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Brainsway Ltd. Sponsored ADR stock logo
BWAY
Brainsway
N/A
5.03
4.75
SEPA
SEP Acquisition
N/A
0.57
0.57
Neuronetics, Inc. stock logo
STIM
Neuronetics
1.40
2.44
2.28
Tactile Systems Technology, Inc. stock logo
TCMD
Tactile Systems Technology
0.11
4.52
3.99

Institutional Ownership

CompanyInstitutional Ownership
Brainsway Ltd. Sponsored ADR stock logo
BWAY
Brainsway
30.11%
SEPA
SEP Acquisition
3.66%
Neuronetics, Inc. stock logo
STIM
Neuronetics
53.59%
Tactile Systems Technology, Inc. stock logo
TCMD
Tactile Systems Technology
83.43%

Insider Ownership

CompanyInsider Ownership
Brainsway Ltd. Sponsored ADR stock logo
BWAY
Brainsway
19.00%
SEPA
SEP Acquisition
20.00%
Neuronetics, Inc. stock logo
STIM
Neuronetics
8.70%
Tactile Systems Technology, Inc. stock logo
TCMD
Tactile Systems Technology
2.50%
CompanyEmployeesShares OutstandingFree FloatOptionable
Brainsway Ltd. Sponsored ADR stock logo
BWAY
Brainsway
12018.90 million15.31 millionNot Optionable
SEPA
SEP Acquisition
25.81 million4.65 millionNot Optionable
Neuronetics, Inc. stock logo
STIM
Neuronetics
18066.11 million60.36 millionOptionable
Tactile Systems Technology, Inc. stock logo
TCMD
Tactile Systems Technology
1,03723.25 million22.67 millionOptionable

Recent News About These Companies

Small-cap write on sticky notes isolated on wooden table.
3 Small Caps Drawing Insider and Institutional Support (TCMD)
...
Tactile Systems stock tumbles after Q1 miss

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Brainsway stock logo

Brainsway NASDAQ:BWAY

$11.61 -0.54 (-4.44%)
Closing price 04:00 PM Eastern
Extended Trading
$11.76 +0.15 (+1.25%)
As of 05:32 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

BrainsWay Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States and internationally. It offers Deep Transcranial Magnetic Stimulation platform technology for the treatment of major depressive disorders, anxious depression, obsessive-compulsive disorders, smoking addiction, bipolar disorders, post traumatic stress disorders, schizophrenia, Alzheimer's disease, autism, chronic pain, multiple sclerosis, post stroke rehabilitation, and Parkinson's diseases. The company serves doctors, hospitals, and medical centers in the field of psychiatry. BrainsWay Ltd. was founded in 2003 and is headquartered in Jerusalem, Israel.

SEP Acquisition NASDAQ:SEPA

SEP Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, stock purchase, reorganization, or related business combination with one or more businesses. The company was formerly known as Mercury Ecommerce Acquisition Corp. and changed its name to SEP Acquisition Corp. in December 2022. The company was incorporated in 2021 and is based in Houston, Texas. SEP Acquisition Corp. is a subsidiary of Mercury Sponsor Group I LLC.

Neuronetics stock logo

Neuronetics NASDAQ:STIM

$3.83 +0.23 (+6.39%)
Closing price 04:00 PM Eastern
Extended Trading
$3.84 +0.02 (+0.39%)
As of 06:04 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive disorder. Its NeuroStar Advanced Therapy System uses transcranial magnetic stimulation to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company sells its products through its sales and customer support team to psychiatrists. The company was incorporated in 2001 and is headquartered in Malvern, Pennsylvania.

Tactile Systems Technology stock logo

Tactile Systems Technology NASDAQ:TCMD

$10.01 +0.22 (+2.25%)
Closing price 04:00 PM Eastern
Extended Trading
$10.34 +0.34 (+3.35%)
As of 06:02 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Tactile Systems Technology, Inc., a medical technology company, develops and provides medical devices to treat underserved chronic diseases in the United States. It offers Flexitouch Plus system, a pneumatic compression device for the treatment of lymphedema in the home setting; and Entre Plus System, a portable pneumatic compression device for the at-home treatment of venous disorders, such as lymphedema and chronic venous insufficiency, including venous leg ulcers. The company also provides Kylee, a mobile application to help patients learn about lymphedema, track their symptoms, and treatment, as well as to share their progress with their doctor; and AffloVest, a portable high frequency chest wall oscillation vest to treat patients with retained pulmonary secretions resulting from bronchiectasis, cystic fibrosis, and various neuromuscular disorders. Tactile Systems Technology, Inc. was incorporated in 1995 and is headquartered in Minneapolis, Minnesota.